>_ QFI Terminal
Terminal › Stocks › ELAB

PMGC Holdings Inc. (ELAB) Stock

Healthcare · Biotechnology · US
$0.56 -0.95%
Last updated Sep 20, 2026 14:59 UTC

ELAB Key Statistics

Market Cap$1.07M
P/E (TTM)0.00
P/S (TTM)1.82
P/B (TTM)0.00
Revenue (TTM)$590,084.00
EPS (TTM)$-449.60
Dividend Yield—
ROE (TTM)-92.02%
Net Margin-1,306.28%
Gross Margin12.68%
52W High$14.00
52W Low$0.54
Analyst View—
Price Target—
Employees2
Volume124,685

About PMGC Holdings Inc.

PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operates investment firms. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.

CEO: Graydon Bensler. Company website

ELAB — Frequently Asked Questions

What is the ELAB stock price today?

PMGC Holdings Inc. (ELAB) trades at $0.56, down 0.95% on the day, as of Sep 20, 2026 14:59 UTC.

What is PMGC Holdings Inc.'s market cap?

PMGC Holdings Inc. has a market capitalisation of $1.07M, calculated from the live ELAB share price and shares outstanding.

What is the P/E ratio of ELAB?

ELAB has no meaningful price-to-earnings ratio: PMGC Holdings Inc. lost $449.60 per share over the last twelve months, and a P/E is only defined on positive earnings.

How much revenue does PMGC Holdings Inc. make?

PMGC Holdings Inc. generated revenue of $590,084.00 over the trailing twelve months, which puts the stock at 1.82 times sales.

What is the 52-week range for ELAB?

ELAB has traded between $0.54 and $14.00 over the past 52 weeks, and the last price is 96.0% below that high.

Is PMGC Holdings Inc. profitable?

No. PMGC Holdings Inc. is loss-making, with a net margin of -1,306.28% over the trailing twelve months.

What sector is PMGC Holdings Inc. in?

PMGC Holdings Inc. is classified under the Healthcare sector and the Biotechnology industry, and is domiciled in US .

Who is the CEO of PMGC Holdings Inc.?

Graydon Bensler is the chief executive of PMGC Holdings Inc., which employs 2 people.

Where can I track ELAB in real time?

QFI Terminal shows ELAB with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.

See ELAB live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open ELAB in Terminal See plans

Biotechnology stocks

REGN Regeneron Pharmaceuticals, Inc. VRTX Vertex Pharmaceuticals Incorporated ONC BeOne Medicines AG ARGX argenx SE INCY Incyte Corporation ALNY Alnylam Pharmaceuticals, Inc. JAZZ Jazz Pharmaceuticals plc GMAB Genmab A/S

More Healthcare stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corp. MCK McKesson Corporation COR Cencora, Inc. NVO Novo Nordisk A/S CI Cigna Corporation CAH Cardinal Health, Inc. ELV Elevance Health Inc.